2025-04-11T12:01:29-05:00 2024-12-31 232939307 HOLSINGER PC 117 VIP DRIVE STE 220 WEXFORD PA 15090 990 2024-01-01 870957020 HAPPY LUNGS PROJECT HAPP 5123379352 3209 SUNNY LANE AUSTIN TX 78731 NED STEWART TREASURER 5123379352 2025-04-10 1 0 ANDY BIANCO P01995396 7249344880 2025-04-10 2024 2025-03-06 01:10:19Z NED STEWART 3209 SUNNY LANE AUSTIN TX 78731 554878 0 X WWW.HAPPYLUNGSPROJECT.ORG X 2021 TX TO SUPPORT RESEARCHERS AND CLINICIANS IN THEIR WORK TOWARD FINDING A CURE FOR RET POSITIVE NON-SMALL CELL LUNG CANCER, WHILE PROVIDING HELPFUL INFORMATION TO EMPOWER EACH PATIENT IN THEIR OWN HEALING. 3 3 1 0 0 0 362802 554878 0 0 0 0 0 0 362802 554878 0 467607 0 0 110105 86783 0 0 89904 514167 77737 624272 632127 -261470 -77249 466477 389228 0 0 466477 389228 TO SUPPORT RESEARCHERS AND CLINICIANS IN THEIR WORK TOWARD FINDING A CURE FOR RET POSITIVE NON-SMALL CELL LUNG CANCER, WHILE PROVIDING HELPFUL INFORMATION TO EMPOWER EACH PATIENT IN THEIR OWN HEALING. 0 0 538608 467607 PROVIDE SUPPORT FOR RESEARCHERS AND CLINICIANS IN FINDING A CURE, RAISING AWARENESS ABOUT TESTING METHODS FOR EARLY DETECTION OF NSCLC MUTATIONS, DEVELOPING INDIVIDUALIZED THERAPIES BASED UPON NEW TESTING AND DIAGNOSTICS, INCLUDING METHODS TO COMBAT DEVELOPMENT OF TARGETED THERAPY RESISTANCE, DETERMINING IF EXISTING PHARMACEUTICALS CAN BE REPURPOSED OR COMBINED WITH OTHER TREATMENTS TO PROVIDE EFFECTIVE, NOVEL TREATMENTS, AND DEVELOPING NEW IMMUNOTHERAPIES WHICH CAN BE USED IN CONJUNCTION WITH EXISTING TREATMENTS, OR EMPLOYED AS PRIMARY THERAPY. 538608 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 1 0 0 0 0 0 0 0 0 0 0 X 3 3 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 X ILANA STROMBERG 5123379352 3209 SUNNY LANE AUSTIN TX 78731 X NED STEWART TREASURER 2.00 X X 0 0 0 ILANA STROMBERG SECRETARY 2.00 X X 0 0 0 MARK STRAMA CHAIRMAN 2.00 X X 0 0 0 0 0 0 0 0 0 0 0 554878 554878 554878 0 0 0 467607 467607 80000 80000 6783 6783 720 720 3950 3950 65029 61908 3121 1023 1023 2477 573 1904 1517 1517 OTHER EXPENSES 2697 1262 1435 BANK FEES 324 48 276 632127 538608 3615 89904 466477 389228 466477 389228 0 0 X 466477 389228 466477 389228 466477 389228 -77249 0 X 0 0 0 X 216750 922265 362802 554878 2056695 216750 922265 362802 554878 2056695 0 0 0 2056695 216750 922265 362802 554878 2056695 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT ST BOSTON MA 02114 123486 0 RESEARCH GRANTS FOCUSED ON RET RELATED DISEASE MD ANDERSON CANCER CENTER 1515 HOLCOMBE BLVD HOUSTON TX 77030 215103 0 RESEARCH GRANTS FOCUSED ON RET RELATED DISEASE MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVE NEW YORK NY 10065 96937 0 RESEARCH GRANTS FOCUSED ON RET RELATED DISEASE UT SOUTHWESTERN MEDICAL CENTER 5323 HARRY HINES BLVD DALLAS TX 75390 32081 0 RESEARCH GRANTS FOCUSED ON RET RELATED DISEASE PART I, LINE 2: WE COLLABORATE WITH THOSE STUDYING THE BIOLOGY OF RET-DRIVEN MALIGNANCIES OF ALL TYPES, REGARDLESS OF THEIR INSTITUTIONAL AFFILIATION, SO THAT OUR EFFORTS CAN BENEFIT PATIENTS AFFECTED NOT JUST BY NSCLC, BUT ALSO THOSE WITH OTHER RET-DRIVEN CANCERS. WE ALSO FACILITATE DEVELOPMENT OF TREATMENT OPTIONS FOR PATIENTS WHO EXHIBIT RESISTANCE TO EXISTING RET MEDICATIONS. BASED ON THE COUNCIL OF OUR SCIENTIFIC ADVISORY BOARD, WE EVALUATE LATE-STAGE CLINICAL TRIALS WHICH SHOW PROMISE AND NEED FUNDING TO COMPLETE CRITICAL WORK, AS WELL AS NOVEL, EARLY-STAGE RESEARCH. FORM 990, PART VI, SECTION B, LINE 11B A DRAFT COPY OF THE 990 IS PROVIDED TO EVERY BOARD MEMBER PRIOR TO THE MAILING DUE DATE. EACH MEMBER IS ASKED TO REVIEW AND NOTATE QUESTIONS AND AREAS OF CLARIFICATION NEEDED. ALL MEMBERS ARE ENCOURAGED TO CALL AT A MINIMUM TO DISCUSS THE ISSUES AND/OR MEET WITH THE NECESSARY PERSONNEL ABLE TO EXPLAIN OR CLARIFY. EACH MEMBER IS ASKED TO SIGN OFF ON A FORM THAT THEY RECEIVED AND REVIEWED THE 990. FORM 990, PART VI, SECTION B, LINE 12C EACH DIRECTOR, OFFICER, AND TRUSTEE IS ASKED TO DISCLOSE RELATIONSHIPS AND INTEREST ANNUALLY. FORM 990, PART VI, SECTION C, LINE 19 UPON RECEIVING A REQUEST FOR SUCH DATA, THE INFORMATION IS PROMPTLY COPIED AND PROVIDED EITHER IN PERSON OR THROUGH CERTIFIED MAIL TO THE INDIVIDUAL MAKING THE REQUEST.